Basic Information
Phio Pharmaceuticals Corp. is a biotechnology company developing next-generation immuno-oncology therapies based on its self-delivering RNAi (INTASYL™) therapeutic platform. Phio Pharmaceuticals is committed to developing innovative cancer treatments that overcome tumor immune suppression and weaponize the immune system to fight cancer without genetic modification.
Phio Pharmaceuticals Corp.
Massachusetts,United States of America
15~50 people
January 01, 2011
admin@RXiPharma.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios